Yamanashi Yoshitaka, Mori Masaki, Terajima Katsuyuki, Tsueshita Takaya, Horinouchi Hirohisa, Sakai Hiromi, Sakamoto Atsuhiro
Department of Anesthesiology, Nippon Medical School, Bunkyo, Tokyo, Japan.
ASAIO J. 2009 Sep-Oct;55(5):478-83. doi: 10.1097/MAT.0b013e3181b17f34.
Transfusion for hemorrhagic shock can improve oxygenation, but immunoreactions may induce inflammation. Artificial oxygen carriers have been developed to address clinical concerns of infection and stability, but whether an artificial oxygen carrier might induce inflammation is not well known. To address this question, we compared inflammatory reactions after resuscitation with hemoglobin vesicles (HbVs) or red blood cells (RBCs) in a hemorrhagic shock rat model. Both HbVs and the stored and irradiated rat RBCs deprived of buffy coat were suspended in recombinant human serum albumin [(Hb) = 8.6 g/dL]. Under anesthesia, hemorrhagic shock was induced for 30 min, followed by resuscitation by 20 min transfusion of HbVs or rat RBCs in a volume equivalent to the volume of withdrawn blood. Lungs were excised 2 or 24 h after resuscitation, and mRNA levels of tumor necrosis factor alpha (TNF-alpha), intercellular adhesion molecule-1 (ICAM-1), nitric oxide synthase 2 (iNOS), nitric oxide synthase 3, hypoxia-inducible factor 1 alpha, and heme oxygenase 1 (HO-1) were measured. In rats resuscitated with HbVs, mRNA levels of TNF-alpha and HO-1 2 h after resuscitation were significantly higher than those in the rat RBC group, but the levels at 24 h were similar in both groups. The expression of iNOS and ICAM-1, second messengers of inflammation, was not affected, and inflammatory levels after 24 h with HbVs are similar to rat RBC transfusion. The rat RBC group did not show an expected inflammatory reaction related to a transfusion-induced lung injury, and a clinical relevance concerning this level of transient inflammatory reaction induced by HbVs is not known; however, attention to the early stage of resuscitation in ongoing studies of HbV is required.
出血性休克输血可改善氧合,但免疫反应可能诱发炎症。已研发出人工氧载体以解决感染和稳定性等临床问题,但人工氧载体是否会诱发炎症尚不清楚。为解决这一问题,我们在出血性休克大鼠模型中比较了用血红蛋白囊泡(HbV)或红细胞(RBC)复苏后的炎症反应。将HbV以及去除了白膜层的储存和辐照大鼠RBC均悬浮于重组人血清白蛋白中([Hb]=8.6 g/dL)。在麻醉状态下,诱导出血性休克30分钟,然后以等同于失血体积的量输注HbV或大鼠RBC进行20分钟的复苏。复苏后2小时或24小时切除肺组织,检测肿瘤坏死因子α(TNF-α)、细胞间黏附分子-1(ICAM-1)、一氧化氮合酶2(iNOS)、一氧化氮合酶3、缺氧诱导因子1α和血红素加氧酶1(HO-1)的mRNA水平。在用HbV复苏的大鼠中,复苏后2小时TNF-α和HO-1的mRNA水平显著高于RBC组,但两组在24小时时的水平相似。炎症第二信使iNOS和ICAM-1的表达未受影响,HbV复苏24小时后的炎症水平与大鼠RBC输血相似。RBC组未出现与输血诱导的肺损伤相关的预期炎症反应,HbV诱导的这种短暂炎症反应水平的临床相关性尚不清楚;然而,在正在进行的HbV研究中需要关注复苏的早期阶段。